Immix Biopharma, Inc. (IMMX) — Institutional Holders, Q2 2026 (page 2)
109 institutional investment managers reported a IMMX position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $579.5M. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 101 to 109. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
IMMX 13F holders ranked 101–109 of 109
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 101 | ROYAL BANK OF CANADA#101 · 1,356 sh | 1,356 | $14.0K | 0.00% | +2198.3% |
| 102 | Pacer Advisors#102 · 977 sh | 977 | $10.0K | 0.00% | New |
| 103 | GROUP ONE TRADING, L.P.#103 · 879 sh | 879 | $9.1K | 0.00% | 0.0% |
| 104 | Sterling Capital Management#104 · 144 sh | 144 | $1.5K | — | New |
| 105 | Quarry#105 · 112 sh | 112 | $1.2K | <0.01% | New |
| 106 | Aspect Partners#106 · 88 sh | 88 | $907.00 | — | +877.8% |
| 107 | FMR#107 · 61 sh | 61 | $629.00 | 0.00% | New |
| 108 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT#108 · 11 sh | 11 | $113.00 | 0.00% | New |
| 109 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM#109 · 566 sh | 566 | — | — | New |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.